Summary Tumour pH plays a significant role in cancer treatment. However, because of the limitations of the current measurement techniques, spatially and temporally resolved pH data, obtained non-invasively in solid tumours, are not available. Fluorescence ratio imaging microscopy (FRIM) has been used previously for noninvasive, dynamic evaluation of pH in neoplastic tissue in vivo (Martin GR, Jain RK 1994, Cancer Res., 54, 5670 -5674 
pH is an important determinant of tumour growth, metabolism and response to various treatment modalities such as chemotherapy, radiation therapy, hyperthermia and photodynamic therapy. Therefore, a detailed knowledge about spatial and temporal variations of tumour pH and its modification is needed, especially since marked intra-and intertumour heterogeneities in interstitial pH have been reported (Song et al., 1993) . Tumour pH has traditionally been measured with techniques which either (1) are invasive [H+-sensitive electrodes (Ashby, 1966) ]; (2) do not provide sufficient spatial resolution [e.g. nuclear magnetic resonance (Daly and Cohen, 1989) , positron emission tomography (Hawkins and Phelps, 1988) , implantable microchambers (Gullino et al., 1965) ]; (3) are not adequate for repeated measurements at a given location (electrodes, microchambers); or (4) do not provide a quantitative analysis of tumour pH with respect to the local haemodynamics.
Recent studies have shown that in vivo fluorescence ratio imaging microscopy (FRIM) is a useful technique for pH measurements in living tissues (Kaneko et al., 1991; Martin and Jain, 1993; Mordon et al., 1994) . It has been successfully used for the determination of interstitial pH profiles in thin (50 gm), essentially two-dimensional tumours grown in the rabbit ear chamber (Martin and Jain, 1994) . The technique provided adequate spatial and temporal resolutions for the non-invasive determination of pH and its modification owing to treatment such as hyperglycaemia and hypercaepnia (Martin and Jain, 1994) . In thick biological tissues, however, the use of quantitative fluorescence microscopy is limited due to: (1) the contribution of out-of-focus light to the tissue slice of interest; (2) significant light scattering and absorption, which not only differ in blood vs interstitium, but may also differentially affect the excitation intensities at two different wavelengths used for ratio imaging (Pittman, 1986) ; and (3) inner filtering and reabsorption phenomena (Tanke et al., 1982; Van Oostveldt and Bauwens, 1990) . To circumvent these problems, we developed a pinhole illumination -optical sectioning (PIOS) adaptation of the FRIM technique, to measure interstitial pH in thick, three-dimensional, solid tumours. Using this approach, we measured the following parameters: (1) interstitial pH profiles, at the microscopic level, in human colon adenocarcinoma tumours xenotransplanted in non-anaesthetised, severe combined immunodeficient (SCID) mice; (2) the effect of systemic glucose injection on spatial and temporal pH profiles; and (3) the effect of microcirculation parameters (e.g. intervessel distance and vessel blood flow) on interstitial pH.
Materials and methods
Animal model Experiments were performed in severe combined immunodeficient (SCID) mice (6-8 weeks old, 25-30 g), bred and housed in our defined flora animal colony. A dorsal skinfold chamber was surgically implanted under anaesthesia (75 mg ketamine hydrochloride/25 mg xylazine per kg s.c.), as described in detail previously (Leunig et al., 1992) . After a 2 day recovery period, a tumour was grown by seeding the dorsal chamber with , 5 x 105 human colon adenocarcinoma cells (LS1 74T; ATCC, Rockville, MD, USA) initially expanded in vitro. Tumour growth and microcirculation were monitored through the glass coverslip of the chamber. pH experiments were performed 20 -25 days after cell implantation, when tumours had reached a discoid shape of % 5 mm in diameter and 2 mm in thickness.
Fluorescence ratio imaging microscopy (FRIM) in thick tissues The imaging station ( Figure 1 
Profiles shown in Figures 4b and c and 5 were obtained by averaging pixel intensities from 10 x 5 pm2 rectangular windows within a spot image (spatial resolution of 5 pm).
Ratios were then converted into pH values using an ex vivo calibration curve (see below).
Calibration of ratio measurements Two calibration methods were used; (1) an in vitro method, where the fluorescence ratios of BCECF, added to standard pH buffers (mixtures of monobasic and dibasic sodium phosphate at 300 mOsm) in 0.2 mm thick glass capillaries (Vitro Dynamics, Rockaway, NJ, USA), were determined; and (2) an ex vivo method, where excised normal subcutaneous tissue and tumour tissue were first incubated for 30 min at 25'C in dye-free buffers of defined pH, then transferred to the same pH buffers mixed with 0.002 mg ml-' BCECF and incubated for 10 min, and finally placed under the microscope for ratio measurements, The optical configuration was the same as the one used for in vivo measurements.
Statistics
Results are presented as mean + s.e.m. Values of several groups were compared with the Wilcoxon test for dependent groups, and the Kruskal -Wallis and the Mann -Whitney U-test for independent groups respectively (Statview; Abacus, Berkeley, CA, USA). The Spearman's correlation coefficient was calculated to analyse correlation between parameters. P-values smaller than 5% were considered to be significant.
Results
Fluorescence ratio imaging in thick samples: the PIOS scheme To improve fluorescence measurements in thick samples, an optical sectioning effect (or partial confocal effect) was created by introducing pinhole diaphragms of different diameters in the path of the excitation light beam (Figure 1) . First, the depth-of-light collection was determined in vitro. A sodium phosphate buffer solution was placed in cuvettes with increasing depths (0 to 800 pm), with a fixed concentration (0.002 mg ml-') of the BCECF probe. Widefield illumination (i.e. no diaphragm in the excitation path) resulted in a steady increase in fluorescence intensities with increasing depths (0-800 pm), both at 440 and 495 nm; it evidenced the contamination of the in-focus fluorescence by out-of-focus haze. In contrast, the use of a 40 pum pinhole in the excitation light path limited the depth-of-light collection to 40 pm at both wavelengths ( Figure 2 ). Importantly, fluorescence ratios, as determined by equation (1), were stable at any depth >40,pm using a 40 pm pinhole, whereas they decreased drastically with increasing depths under widefield excitation (data not shown).
The effects of this pinhole configuration on fluorescence ratios were investigated further by progressively decreasing the size of the illumination spot (pinhole diaphragm) focused on the fluorescent sample. At a fixed cuvette depth (800 pm), fluorescence ratios decreased with decreasing apertures, until a minimum ratio was reached with the 40 pm pinhole. A further reduction in the aperture (20 pm pinhole) did not significantly affect the ratio. The same study was performed in vivo, in a 2-mm-thick LS174T tumour grown in the dorsal skinfold chamber. Results were similar to the in vitro case, namely a stable fluorescence ratio with apertures less than or equal to 40 pm (data not shown). Thus, for subsequent in vivo studies, the 40 pm pinhole aperture was used, since it provided stable ratios, while maintaining a sufficiently high fluorescence emission signal. In vitro calibration (see Materials and methods) was performed over a wide pH range (4.51-9.25), using the pinhole configuration on the microscope. As expected, a sigmoidal relationship between pH and the measured fluorescence ratio at 495 and 440 nm was obtained (insert, Figure 3 ). In the 6.20-7.80 pH range, the relationship was well approximated by a linear fit (r2 = 0.99; open symbols, Figure 3 ). Ex vivo calibration of excised normal (subcutaneous) and tumour tissues again revealed a linear relationship (r2=0.98 in both cases; closed symbols, Figure 3 ) between actual pH and measured ratios, in the pH range of interest for subsequent in vivo studies (6.20-7.40 ). Different slopes were observed between the two ex vivo curves; these reflect intrinsic spectroscopic differences in tumour vs normal tissues. Accordingly, when reporting tumour vs normal tissue data in vivo, the corresponding ex vivo calibration curves were used.
Tumour interstitial pH is lower than normal subcutaneous pH The modified FRIM technique was used to measure interstitial pH in the 21-day-old, LS174T human colon adenocarcinoma xenograft (N= 6 animals) and in normal subcutaneous tissue (N= 6). Tumour interstitial pH was 6.96+0.03 (+s.e.m.), which was significantly lower than the pH of subcutaneous tissue (7.37 + 0.09).
Interstitial pH gradients The application of FRIM to thick tissues in vivo using the PIOS modification made it possible to obtain local interstitial pH profiles in three-dimensional solid tumours. Figure 4a depicts two tumour blood vessels, 38 ,um (left) and 29 ,Im (right) in diameter, separated by a distance of 120 ,um. Figure  4b shows the corresponding interstitial pH profile between the two vessels. A definite pH gradient, starting from either vessel, was observed. Highest pH (pHmax= 7.44) was recorded 10 pm away from the vessels; pH then gradually decreased to reach a minimum (pHmin = 7.15; ApH = pHmax-pHmin = 0.29) around the midpoint of the intervessel distance.
Ratio measurements less than 10 gm from a blood vessel were not valid owing to differential light absorption by blood haemoglobin at 440 and 495 nm. This always resulted in an uncontrollable distortion of the ratio signal, within the vessel and in its proximity (< 10 gm). Also, when choosing tumour locations at the beginning ofeach experiment, it was checked, by focusing the microscope through the sampling volume, that no underlying blood vessels were crossing the in-focus interstitial area of interest. The possible presence of an 'invisible' vessel during the interstitial scan was readily identified during offline analysis by spurious jumps in the ratio signal (2-to 5-fold increase in ratio); such profiles were discarded from subsequent analyses. To confirm these observations, we performed control experiments in vitro using saline solutions mixed with mouse blood at different haematocrits (HT), at pH= 7.2. Compared with the pH ratio of a control saline solution (no RBC), the ratios of solutions adjusted to normal mouse arterial blood HT, 1/10 normal HT, and 1/100 HT showed 9.0-fold, 7.5-fold, and 2.2-fold increases respectively.
For a given intervessel distance, interstitial pH gradients could exhibit different shapes, such as: (1) a parabolic shape, as shown in Figure 4b , with a local minimum around the midpoint of the intervessel distance (7 out of 17 profiles); (2) a skewed parabolic shape, with the local minimum being closer to one of the two vessels (7/17); or (3) a 'cuvette' shape (Figure 4c ), characterised by an initial steep pH decrease from both vessel sides and a low, flat interstitial pH profile in between (3/17).
The relationship between the intervessel distance and the maximal pH drop, ApH, was studied. ApH was defined as the difference between pHmax, the pH measured 10 ,um from one of the two blood vessels, and pHmin, the minimum pH measured between the two vessels. Blood vessels with comparable diameters (20+3 jgm, mean+s.e.m.), RBC velocities (0.15+0.02 mm s-1) and hence flow rates were selected. Figure 4d shows that ApH significantly increased with increasing intervessel distances (Spearman correlation coefficient, rs=0.723; P<0.001).
Glucose-induced modification of pH gradients in solid tumours In any given tumour location, a bolus injection of glucose (6 g kg-' i.v.) induced a decrease in pH of at least 0.1 pH unit (31 locations in ten tumours). Hyperglycaemia did not significantly change interstitial pH of normal subcutaneous tissue (data not shown). The effect of glucose on tumour interstitial pH gradients is shown in detail in Figure 5 . Fortyfive minutes after glucose treatment, interstitial pH monotonically decreased with increasing distance from the blood vessel, resulting in a pH gradient which was very similar in shape (i.e. no significant changes in slope), but significantly lower, compared with the gradient observed before glucose injection. Ninety minutes after glucose administration, the pH gradient had returned to near-baseline values ( Figure 5 ). When compared with pretreatment values, local blood flow (in the vessel adjacent to the area of pH measurement) was not affected, 45 and 90 min after glucose injection. This was evidenced by no significant changes in the measured RBC velocities and vessel diameters (Table I ) and in the corresponding flow rates.
Temporal dynamics and intratumour heterogeneity of glucoseinduced pH changes Figure 6a is a low-magnification, transillumination image of a 21-day-old LS174T tumour xenograft. Heterogeneous vascularisation is evidenced by vessel-rich areas (e.g. labels #3, 4 and 5), areas totally devoid of blood vessels (e.g. label #1), and areas at the interface between the two (e.g. labels #2 and 6). Using the PIOS-modified fluorescence ratio imaging technique, we measured temporal pH dynamics in such interstitial areas, before and after glucose treatments. Distance from vessel (gim) Figure 5 Interstitial pH as a function of distance from the blood vessel. 0, before glucose; [l, 45min after glucose injection (6 g kg-' i.v.); *, 90 min after glucose. Data were averaged over a total of n = 13 locations in 6 tumours. Mean+ s.e.m. is shown. Figure 6b shows that baseline pH, while remaining relatively stable within a 25 min period, could be extremely heterogeneous among different tumour locations. Lowest pH was always found within or near avascularised areas (curves #1, 2 and 6 in Figure 6b , which match the labels in Figure 6a ). Figure 6b further shows that glucose induced a pH decrease in all areas. However, the temporal characteristics differed, with an earlier and/or sharper pH drop in vascularised areas (curves 4 and 5, Figure 6b ), as compared with non-vascularised areas (curves 1, 2 and 6, Figure 6b ). This was confirmed by averaging the data over several such locations in N= 5 tumours. In well-vascularised areas, a significant pH drop of nearly 0.15 pH unit was evident 20 min after glucose injection (closed symbols, Figure 6c ). In non-vascularised areas, pH decrease was more progressive and significantly dropped by -0.15 pH unit after 60 min (open symbols, Figure 6c ), a time point at which pH was already returning to baseline values in vascularised areas. (Figure 4b ). The average pH decrease, away from the blood vessel (0.14 units at 50 gm; Figure 5 ) was similar to that reported by Martin and Jain (1994) for a thin tumour model (0.13 units at 50,m). However, in the latter case, the average pH gradient, 30 Mm away from the blood vessel, was nearly zero; in the present study, pH kept decreasing monotonically in the 10 to 70 Mm range. This may be expected from our three-dimensional experimental tumours, where acid accumulation in the full thickness of the tissue is possible. The gradient data ( Figure  5 ) confirm theoretical predictions made for solid tumours (Von Ardenne and Von Ardenne, 1977) and tumour spheroids (Casciari et al., 1992a Vaupel, 1988; Vaupel et al., 1981) ; and (2) an increased glucose consumption rate by tumour spheroids with decreased oxygen concentration (Casciari et al., 1992b) . pH gradients could be further steepened by poor removal of metabolic waste products, owing to inadequate vascularisation and/or insufficient local blood flow (Jain, 1988) . Enhanced glycolysis (Casciari et al., 1992b) , higher pCO2 and dissolved carbon dioxide levels (Gullino et al., 1965) , and lower bicarbonate concentration (Gullino et al., 1965) in the interstitium would then all contribute to decreasing pH values away from the blood vessel. Interestingly, not all pH profiles were symmetric about the midpoint of the intervessel distance. Skewed parabolic shapes, with the local minimum being closer to one of the two vessels, were measured. Such profiles could be explained by differential blood flow between the two surrounding vessels, and, subsequently, differential nutrient delivery and metabolic waste removal rates. Heterogeneity of metabolic rates among tumour cells may also be a factor. Alternatively, asymmetric profiles could be generated by underlying blood vessels, at a depth where they would not contribute to the ratio signal (see Results), but affect the metabolism of the overlying tissue through diffusion of nutrients and/or metabolites. pH profiles exhibiting a 'cuvette' shape (i.e. an initial steep pH decrease from each vessel side and a low flat pH profile in between) were also measured (Figure 4c ). This pH plateauing could reflect limits in glucose consumption and glycolysis rates at low extracellular pH. Such an inhibition of the Crabtree-like effect has been reported earlier in: (1) tumour cells in vitro, where a 38% decrease in glucose consumption rate was induced when pH was reduced from 7.0 to 6.5 (Rotin et al., 1986) ; and (2) tumour spheroids, where the glucose consumption rate decreased by %60% when pH was changed from 7.25 to 6.95 (Casciari et al., 1992b) . In addition, lactate transport out of the cell is known to be inhibited at low extracellular pH in vitro (Spencer and Lehninger, 1976) , which would further contribute to this plateauing effect.
A significant, positive correlation was found between the maximal pH drop (from the vessel to the intervessel (Figure 4d ). This is expected, since interstitial pH will depend markedly on the local degree of vascularisation, network arrangement of vessels, and tumour blood flow, all of which are known to be largely heterogeneous in tumours (Jain, 1988; Vaupel et al., 1989 Figure 6c ) were smaller and more rapid than those reported by Martin and Jain (1994) (Ward and Jain, 1988) .
We further show that the temporal dynamics of glucoseinduced pH decrease strongly depend on tumour location and vascularisation ( Figure 6 ). Although the pH drop following a bolus glucose injection was transient in all cases (Figure 6b ), the response and recovery times were faster, and most importantly, the maximum pH drop occurred earlier, when comparing densely vascularised to avascular areas ( Figure  6c ). This may be directly related to the blood flow-dependent availability of the glucose substrate (Kallinowski et al., 1988) . Interestingly, averaging the data over different locations within a tumour at different time points (Figure 6b , bold line) resulted in a glucose-induced pH response which could be either similar to (e.g. Figure 6 , curve 3), or significantly different from (e.g. Figure 6 , curves 1 and 5) the response of individual locations. Such results should help to sort out part of the heterogeneity reported on this subject in the literature, which may not be solely due to differences in experimental protocols (Ward and Jain, 1988 al., 1993) .
The glucose data support the idea that hyperglycaemia can be used as an adjuvant treatment to decrease interstitial tumour pH acutely and selectively. This would be particularly useful in therapies, such as hyperthermia, where tumour cells which are chronically exposed to low pH become treatment resistant. However, differences in the spatial and temporal courses of the response exist and must be considered carefully (Figure 6c ). In contrast, the present study (Table II) , as well as the data of Jahde and Rajewsky (1982), do not confirm the initial report on selective tumour acidification induced by sodium bicarbonate ingestion (Gullino et al., 1965) . Thus, selective bicarbonate-induced decrease in interstitial tumour pH appears to be more species-and/or tumour-specific than hyperglycaemia-induced tumour acidification.
Advantages and limitations of the PIOS-FRIM technique
In the wide-field illumination mode or with any diaphragm aperture >40 ,um, stable fluorescence ratios could not be obtained in vitro. When applied in vivo, the situation worsened, owing to significant light scattering by the thick tissue sample. During the imaging process, scattering was evidenced by a halo of fluorescence emission light (excluded from the analysis), which was imaged outside the original excitation spot; it could extend > 1 spot diameter beyond the spot area and strongly depended on the tissue location (not shown). As a result, fluorescence ratios obtained in the widefield mode were unstable, even under baseline conditions. Another source of error in the wide-field mode came from the possible presence of unseen underlying blood vessels. These would certainly distort the ratio signal, since: (1) contamination of the emission image by scattered light and differential light absorption was minimised. The trade-off was an increase in acquisition time and storage space; thus, a gradient measurement necessitated scanning of the excitation spot along the chosen gradient line. However, time resolution was still adequate for the pH dynamics reported here.
Also, at physiological interstitial pH (7.2-7.4), the BCECF probe, with a pK. of 6.98, is mostly in its ionised (non-protonated) form, with four to five negative charges. However, as interstitial tumour pH decreases to more acidic values (< 7.0), an increasing fraction of the probe will become protonated and may permeate the tumour cell membrane. Thus, at low interstitial pH (<7.0), intracellular fluorescence may contribute to the extracellular pH signal reported in this study. We believe this effect is negligible for the following reasons: (1) BCECF has different pK. values for each of its ionising groups, and the entry of BCECF into cells would depend upon protonation of all of the charged groups, a rare event at pH values reported in this study; (2) our measurements using the cell-impermeable probe BCECFdextran (MW 10 000, 80 mg kg-' i.v.; Molecular Probes) resulted in pH values virtually identical to those obtained with BCECF-acid (data not shown); and (3) rapid interstitial clearance of the BCECF-acid probe (<1 h; data not shown) argues against intracellular traDping.
In the future, the FRIM technique may be further adapted and used in combination with a phosphorescence quenching technique (Torres-Filho et al., 1994) , to evaluate noninvasively extracellular pH, intracellular pH and P02 in solid tumours transplanted in the dorsal chambers in mice.
Using glycolysis-deficient cells (Pouyssegur et al., 1980) , the simultaneous knowledge of pH/pO2 may help determine the origin of non-glycolytic acidification, as reported in some tumours (Hwang et al., 1992; Newell et al., 1993) . Abbreviations BCECF, 2',7'-bis-(2-carboxyethyl)-5,6-carboxyfluorescein; FRIM, fluorescence ratio imaging; PIOS; pinhole iUlumination and optical sectioning; RBC, red blood ceUl; SCID, severe combined immunodeficient.
